Open AccessS106: LONG‐TERM FOLLOW‐UP OF BETA‐THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY
Author(s) -
Marktel S,
Scaramuzza S,
Giglio F,
Cicalese M,
Lidonnici M,
Rossi C,
Calbi V,
Masera N,
D'Angelo E,
Mirra N,
Origa R,
Tartaglione I,
Perrotta S,
Viarengo G,
Santoleri L,
Milani R,
Gattillo S,
Calabria A,
Montini E,
Graziadei G,
Naldini L,
Cappellini M,
Aiuti A,
Ciceri F,
Ferrari G
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000821392.30462.2e
Subject(s) - genetic enhancement , stem cell , medicine , viral vector , hematopoietic stem cell transplantation , thalassemia , hematopoietic stem cell , adverse effect , haematopoiesis , cd34 , transplantation , neutropenia , immunology , bone marrow , oncology , gastroenterology , biology , chemotherapy , gene , genetics , recombinant dna